MFFAIS - Mutual Fund Facts About Individual Stocks       
 
 
 
Home | About | News | Terms | Contact | Help | FAQ | Funds | Institutions | Stocks | Rankings
 0  1  2  3  4  5  6  7  8  9  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Grant Life Sciences Inc (GLIF.PK)

Industry: Medical Labs&Testing SrvCountry: United States
 
Number of funds
Global RankCountry RankIndustry Rank
Owned:
1
11064593118
Score:
-2.00
11334--
Brand New:
0
7855505016
Increased Existing:
0
7686--
No Change:
0
9273--
Reduced Existing:
0
7238--
Liquidated:
1
7271457412
No Comparison Available:
0
---
Funds buying shares:
0
9120553116
Buying %:
0.00 %
9120553116
Funds not buying/selling shares:
0
---
Neutral %:
0.00 %
---
Funds selling shares:
1
8280512316
Selling %:
100.00 %
111
   

Grant Life Sciences Inc (GLIF.PK) Details

Click on column headings to sort!
Fund Fund Type Fund Perf. Report Date Current Shares Current Value Value Chng. Return Activity Shares Chng. Shares Chg.% Results
Maple Capital Management Inc Institution -10.42 % 2008-04-24 None - - - % Sold All -448,860 -100.00 % $4,489
 0  1  2  3  4  5  6  7  8  9  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
Listed 1 holdings.
   
Grant Life Sciences Inc on Google Grant Life Sciences Inc on Yahoo Grant Life Sciences Inc on CNN Money Grant Life Sciences Inc on MSN Grant Life Sciences Inc on Reuters Grant Life Sciences Inc on Market Watch Grant Life Sciences Inc on Forbes
 
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits!
Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically!
Copyright © 2007 All rights reserved. Please see our Terms of Use.